The monetary valuation of informal care to cancer decedents at end-of-life: Evidence from a national census survey.


Journal

Palliative medicine
ISSN: 1477-030X
Titre abrégé: Palliat Med
Pays: England
ID NLM: 8704926

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 23 1 2021
medline: 21 5 2021
entrez: 22 1 2021
Statut: ppublish

Résumé

Carers' end-of-life caregiving greatly benefits society but little is known about the monetary value of this care. Within an end-of-life cancer setting: (1) to assess the feasibility and content validity of a post-bereavement measure of hours of care; and (2) to obtain a monetary value of this informal care and identify variation in this value among sub-groups. A census based cross-sectional survey of all cancer deaths from a 2-week period in England collected detailed data on caregiving activity (10 caregiving tasks and the time spent on each). We descriptively analyse the information carers provided in 'other' tasks to inform content validity. We assigned a monetary value of caregiving via the proxy good method and examined variation in the value via regression analysis. The majority of carers (89.9%) were able to complete the detailed questions about hours and tasks. Only 153 carers reported engaging in 'other' tasks. The monetary value of caregiving at end-of-life was £948.86 per week with social and emotional support and symptom management tasks representing the largest proportion of this monetary valuation. Time of recall did not substantially relate to variation in the monetary value, whereas there was a stronger association for the relationship between the carer and recipient, carer gender and recipient daily living restrictions. The monetary valuation we produce for carers' work is substantial, for example the weekly UK Carers' Allowance only amounts to 7% of our estimated value of £948.86 per week. Our research provides further information on subgroup variation, and a valid carer time instrument and method to inform economic evaluation and policy.

Sections du résumé

BACKGROUND
Carers' end-of-life caregiving greatly benefits society but little is known about the monetary value of this care.
AIM
Within an end-of-life cancer setting: (1) to assess the feasibility and content validity of a post-bereavement measure of hours of care; and (2) to obtain a monetary value of this informal care and identify variation in this value among sub-groups.
DESIGN AND SETTING
A census based cross-sectional survey of all cancer deaths from a 2-week period in England collected detailed data on caregiving activity (10 caregiving tasks and the time spent on each). We descriptively analyse the information carers provided in 'other' tasks to inform content validity. We assigned a monetary value of caregiving via the proxy good method and examined variation in the value via regression analysis.
RESULTS
The majority of carers (89.9%) were able to complete the detailed questions about hours and tasks. Only 153 carers reported engaging in 'other' tasks. The monetary value of caregiving at end-of-life was £948.86 per week with social and emotional support and symptom management tasks representing the largest proportion of this monetary valuation. Time of recall did not substantially relate to variation in the monetary value, whereas there was a stronger association for the relationship between the carer and recipient, carer gender and recipient daily living restrictions.
CONCLUSION
The monetary valuation we produce for carers' work is substantial, for example the weekly UK Carers' Allowance only amounts to 7% of our estimated value of £948.86 per week. Our research provides further information on subgroup variation, and a valid carer time instrument and method to inform economic evaluation and policy.

Identifiants

pubmed: 33478364
doi: 10.1177/0269216321989569
pmc: PMC8022080
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

750-758

Subventions

Organisme : Wellcome Trust
ID : 212812/Z/18/Z
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Références

Appl Health Econ Health Policy. 2013 Jun;11(3):193-203
pubmed: 23549793
Health Econ. 2006 May;15(5):447-60
pubmed: 16389664
Palliat Med. 2010 Jul;24(5):523-32
pubmed: 20348270
Palliat Med. 2017 Apr;31(4):323-337
pubmed: 27670418
Soc Sci Med. 2010 Nov;71(10):1890-5
pubmed: 20884103
BMJ Support Palliat Care. 2019 Sep;9(3):300-306
pubmed: 28213346
Eur J Public Health. 2017 Feb 1;27(suppl_1):90-95
pubmed: 28355645
Oncologist. 2010;15(8):883-93
pubmed: 20667966
Eur J Health Econ. 2004 Feb;5(1):36-45
pubmed: 15452763
Palliat Med. 2015 Dec;29(10):899-907
pubmed: 26199134
PLoS One. 2018 Apr 3;13(4):e0195294
pubmed: 29614108
Palliat Med. 2017 Apr;31(4):346-355
pubmed: 28281406
Cancer. 2009 Sep 15;115(18 Suppl):4362-73
pubmed: 19731345
Soc Sci Med. 2006 Feb;62(4):835-45
pubmed: 16137814
Ann Oncol. 2007 Sep;18(9):1539-47
pubmed: 17660496
Qual Life Res. 2018 Jun;27(6):1545-1554
pubmed: 29520559
Health Soc Care Community. 2019 Sep;27(5):e622-e636
pubmed: 31293013
Pharmacoeconomics. 2015 Feb;33(2):123-35
pubmed: 25315368
Eur J Cancer. 2013 May;49(7):1683-91
pubmed: 23265703
Lancet. 2015 Mar 14;385(9972):977-1010
pubmed: 25467588
Health Soc Care Community. 2015 Nov;23(6):605-18
pubmed: 25443659
Support Care Cancer. 2013 Sep;21(9):2583-92
pubmed: 23649879
Ann Oncol. 2012 Aug;23(8):2006-2015
pubmed: 22345118
Eur J Cancer. 2020 Apr;129:41-49
pubmed: 32120274
Clin Pharmacol Ther. 1995 Aug;58(2):228-36
pubmed: 7648773
Pharmacoeconomics. 2017 May;35(5):591-601
pubmed: 28205149
Support Care Cancer. 2017 Jan;25(1):245-253
pubmed: 27624465

Auteurs

Sean Urwin (S)

School of Health Sciences, University of Manchester, Manchester, UK.

Bernard Van den Berg (B)

Department of Health Sciences, VU University Amsterdam, Amsterdam, The Netherlands.

Yiu-Shing Lau (YS)

School of Health Sciences, University of Manchester, Manchester, UK.

Christine Rowland (C)

School of Health Sciences, University of Manchester, Manchester, UK.

Barbara Hanratty (B)

Population Health Sciences Institute, Newcastle University, Newcastle, UK.

Gunn Grande (G)

School of Health Sciences, University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH